Peptidences Pharma Overview
- Year Founded
-
2024
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Peptidences Pharma General Information
Description
Manufacturer of peptides, oligonucleotides, and sterile injectables intended to serve pharmaceutical and biotechnology companies. The company develops APIs, including tirzepatide, semaglutide, and liraglutide, as well as lipid excipients and nanoparticle delivery systems, thereby supporting drug development from clinical research to commercialization with regulatory-compliant production.
Contact Information
Website
www.peptidences.com(Operating Subsidiary)
Corporate Office
- 10200 Plano Road
- Dallas, TX 75238
- United States
Corporate Office
- 10200 Plano Road
- Dallas, TX 75238
- United States
Peptidences Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Peptidences Pharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Peptidences Pharma FAQs
-
When was Peptidences Pharma founded?
Peptidences Pharma was founded in 2024.
-
Where is Peptidences Pharma headquartered?
Peptidences Pharma is headquartered in Dallas, TX.
-
What industry is Peptidences Pharma in?
Peptidences Pharma’s primary industry is Drug Discovery.
-
Is Peptidences Pharma a private or public company?
Peptidences Pharma is a Private company.
-
What is Peptidences Pharma’s current revenue?
The current revenue for Peptidences Pharma is .
-
When was Peptidences Pharma acquired?
Peptidences Pharma was acquired on 23-Dec-2025.
-
Who acquired Peptidences Pharma?
Peptidences Pharma was acquired by Bachem.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
